Dr. David Quinn talks about the lack of advances in bladder cancer over the past 25 years, but looks at some current clinical trials on the horizon looking at targeted oncogenes and targeted tumor suppressor genes.
Call center 888-753-8746
This interview was filmed at the American Society of Clinical Oncology Annual Meeting in Chicago 2012.
David Ian Quinn MBBS Honors Class I, PhD, FRACP is an international expert in the field of clinical trials and molecular correlative studies in genitourinary cancer. Dr. Quinn is the medical director of the Norris Cancer Hospital and Clinics, leader of the Developmental Therapeutics Program for the USC Norris Comprehensive Cancer Center, head of the Section of Genitourinary Medical Oncology and associate professor of Medicine in the Division of Cancer Medicine and Blood Diseases at the Keck School of Medicine of USC.